[A three-year experience with use of mabthera (rituximab) in treatment of indolent non-Hodgkin's disease refractory to standard chemotherapy].

Autor: Korolenko VO, Gershanovich ML, Tikhonova VV

Publikováno v: Voprosy onkologii [Vopr Onkol] 2004; Vol. 50 (4), pp. 421-5.

[Significance of adjuvant radiotherapy in the surgical treatment of patients with non-small-cell lung cancer].

Autor: Bartchuk AS; Prof. N.N. Petrov Research Institute of Oncology, Ministry of Health of the RF, St. Petersburg., Kanaev SV, Wagner RI, Korolenko VO, Baĭkova VS

Publikováno v: Voprosy onkologii [Vopr Onkol] 1998; Vol. 44 (2), pp. 159-63.

[Stimulating and protective effect of recombinant interleukin-1-beta (beta-leukin) on leukopoiesis in chemotherapy of malignant tumors].

Autor: Gershanovich ML, Ketlinskiĭ SA, Filatova LV, Danova LA, Korolenko VO, Simbirtsev AS

Publikováno v: Voprosy onkologii [Vopr Onkol] 1996; Vol. 42 (6), pp. 13-8.